Free Serum Prostate-Specific Antigen and Screening for Prostate Cancer-Reply

JAMA: The Journal of the American Medical Association

Volumn 275, Issue 11, 1996, Pages 838-

  Catalona, William J ^a   Smith, Deborah S ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85008590404     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.1996.03530350019022     Document Type: Letter

References (5)

1. Stenman U-H, Hakama M, Knekt P, Aromaa A, Teppo L, Leinonen J. Serum concentrations of prostate specific antigen and its complex with α-1-antichymotrypsin before diagnosis of prostate cancer. Lancet. 1994;344:1594-1598.
2. Christensson A, Bjork T, Nilsson O, et al. Serum prostate specific antigen complexed to α-1-antichymotrypsin as an indicator of prostate cancer. J Urol. 1993;150: 100-105.
3. Luderer AA, Chen YI, Soriano TF, et al. Measurement of the proportion of free to total prostate-specific antigen improves diagnostic performance of prostate-specific antigen in the diagnostic gray zone of total prostate-specific antigen. Urology. 1995;46:187-194.
4. Bangma CH, Kranse R, Blijenberg BO, Schröder FH. The value of screening tests in the detection of prostate cancer, part I: results of a retrospective evaluation of 1726 men. Urology. 1995;46:773-778.
5. Seaman E, Katz A, Cooner WC, et al. An algorithm for prostate cancer detection based upon PSA, TRUS, DRE, PSA density and PSA velocity. J Urol. 1993;149(pt 2):414A. Abstract.